Home › NDC Lookup › RxCUI directory › RxCUI 198037

Nimodipine 30 MG Oral Capsule — RxCUI 198037

RxNorm drug concept · Semantic clinical drug
RxCUI 198037 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198037
Official nameNimodipine 30 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)320 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nimodipine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Nimodipine is given specifically after a subarachnoid hemorrhage — that's when an aneurysm in the brain ruptures and bleeds into the space around the brain. After that kind of blee...
  • What exactly is nimodipine being used for in my (or my family member's) care?
  • It's a lot, yes — and there's a real pharmacological reason. Nimodipine is eliminated from the body relatively quickly, so blood levels drop fast between doses. Taking it every 4 h...
  • Why does it have to be taken every 4 hours? That's a lot.
📖 Read our full Nimodipine guide →

🕸️ Concept Web — How Nimodipine 30 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nimodipine 30 MG Oral Capsule RxCUI 198037

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nimodipine 7426
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nimotop 196516
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nimodipine Oral Capsule 373087
    • Nimodipine Oral Product 1159235
    • Nimodipine Pill 1159236
    • Nimodipine Oral Capsule [Nimotop] 366716
    • Nimotop Oral Product 1183917
    • Nimotop Pill 1183918
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Nimodipine 30 MG 316355
    • Nimodipine 30 MG Oral Capsule [Nimotop] 207779
    • Nimodipine 30 MG [Nimotop] 568519

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nimodipine 30 MG SCDC · 316355
  • Nimodipine Oral Capsule SCDF · 373087
  • Nimodipine Oral Product SCDG · 1159235
  • Nimodipine Pill SCDG · 1159236

Brand-Name Concepts

  • Nimodipine 30 MG Oral Capsule [Nimotop] SBD · 207779
  • Nimodipine 30 MG [Nimotop] SBDC · 568519
  • Nimodipine Oral Capsule [Nimotop] SBDF · 366716
  • Nimotop Oral Product SBDG · 1183917
  • Nimotop Pill SBDG · 1183918
  • Nimotop BN · 196516

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 198037 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
23155-0512-00 10 BLISTER PACK in 1 CARTON (23155-512-00) / 10 CAPSULE, LI... nimodipine Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2017-11-07
23155-0512-30 3 BLISTER PACK in 1 CARTON (23155-512-30) / 10 CAPSULE, LIQ... nimodipine Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2017-11-07
69452-0209-13 3 BLISTER PACK in 1 CARTON (69452-209-13) / 10 CAPSULE, LIQ... Nimodipine BIONPHARMA INC. 2017-11-21
69452-0209-20 10 BLISTER PACK in 1 CARTON (69452-209-20) / 10 CAPSULE, LI... Nimodipine BIONPHARMA INC. 2017-11-21
Observed labelers: BIONPHARMA INC. (2) · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$1.2072
Range $1.2072–$1.2072 · middle 50% $1.2072–$1.2072 · 4 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.